Generate Biomedicines (GENB)
Nasdaq • GENB • US3709201004
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 29, 2026, ORTEX estimated 14.6% of free float sold short, 8.3 days to cover, cost to borrow 1.09%. Sign up for live short interest data.
Market Cap
1.61b USD | # 4257 in US
Volume
1.22m shares | 18.04m USD
Shares Outstanding
128.35m
Free Float Shares
47.11% | 60.46m
